The utility settlement coin has a boring name. But the project, led by Swiss bank UBS, is one of the most ambitious and most highly anticipated blockchain projects in the works—assuming it really uses a blockchain.
The news: UBS and 13 other financial firms—including major banks in the US, Europe, and Japan—have created a new company to lead the digital currency’s development, reports the Wall Street Journal. The firms have also collectively invested around $63 million in the venture, which aims to let the banks settle cross-border trades faster and more cheaply. The project was first revealed in 2015.
The token: Few technical details have been revealed, but the project supposedly involves building a blockchain-based digital currency. The WSJ describes the token as “both a payment device and a messenger that carries all the information required to complete a trade.” It would be backed by bank-owned fiat currency held in central bank accounts. Rhomaios Ram, chief executive of the new company, called Fnality International, told WSJ that he believes the currency will be “fully operational” within a year.
Blockchain what? The companies in charge are working with a blockchain startup called Clearmatics, and they say the utility settlement coin will be blockchain-based. But we don’t really know what that means. It seems that a blockchain or something like it will play a role, but in 2017 the Financial Times reported that it “isn’t really a blockchain project as much as a market infrastructure project.” Besides, many purists would argue that a network controlled by and open only to banks is not really a blockchain anyway, no matter how blockchain-like its underlying technology may be.
Keep up with the fast-moving and sometimes baffling world of cryptocurrencies and blockchains with our twice-weekly newsletter Chain Letter. Subscribe here. It’s free!
Meta has built a massive new language AI—and it’s giving it away for free
Facebook’s parent company is inviting researchers to pore over and pick apart the flaws in its version of GPT-3
The gene-edited pig heart given to a dying patient was infected with a pig virus
The first transplant of a genetically-modified pig heart into a human may have ended prematurely because of a well-known—and avoidable—risk.
Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging
The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.
Yann LeCun has a bold new vision for the future of AI
One of the godfathers of deep learning pulls together old ideas to sketch out a fresh path for AI, but raises as many questions as he answers.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.